Matches in Wikidata for { <http://www.wikidata.org/entity/Q65385192> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q65385192 description "clinical trial" @default.
- Q65385192 description "ensayu clínicu" @default.
- Q65385192 description "klinisch onderzoek" @default.
- Q65385192 description "клінічне випробування" @default.
- Q65385192 name "SOFIA-LTT Study: A Study of Intermittent Long Term Treatment With PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With HBeAg Negative Chronic Hepatitis B (CHB)." @default.
- Q65385192 name "SOFIA-LTT Study: A Study of Intermittent Long Term Treatment With PEGASYS" @default.
- Q65385192 type Item @default.
- Q65385192 label "SOFIA-LTT Study: A Study of Intermittent Long Term Treatment With PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With HBeAg Negative Chronic Hepatitis B (CHB)." @default.
- Q65385192 label "SOFIA-LTT Study: A Study of Intermittent Long Term Treatment With PEGASYS" @default.
- Q65385192 prefLabel "SOFIA-LTT Study: A Study of Intermittent Long Term Treatment With PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With HBeAg Negative Chronic Hepatitis B (CHB)." @default.
- Q65385192 prefLabel "SOFIA-LTT Study: A Study of Intermittent Long Term Treatment With PEGASYS" @default.
- Q65385192 P1050 Q65385192-03D2F163-C8F0-47DD-AE6F-F7B6104DADC7 @default.
- Q65385192 P1050 Q65385192-1CA2C7F4-FBE2-47F5-9BB3-B2B102448583 @default.
- Q65385192 P1050 Q65385192-25E029A2-F705-4327-AB3A-04CE61426147 @default.
- Q65385192 P1132 Q65385192-AE6E6BF5-62CB-457D-AF35-D55D7C9AED88 @default.
- Q65385192 P1476 Q65385192-33A84D19-71A8-4CFF-82BD-5837558407E9 @default.
- Q65385192 P17 Q65385192-F35A88B0-3555-4F03-8AEA-ED3F8341C0F1 @default.
- Q65385192 P2899 Q65385192-AC11B1C0-4FEC-49BB-8F65-38162219D0B1 @default.
- Q65385192 P3098 Q65385192-838A32F8-17CB-45B8-BB68-345252A7C3BF @default.
- Q65385192 P31 Q65385192-AD6E1D87-2EC9-48B1-9A39-DEE924F0DCD5 @default.
- Q65385192 P4844 Q65385192-C41F36A2-909E-4D80-851E-E1B068BECCE8 @default.
- Q65385192 P580 Q65385192-BED87369-C0A9-41A0-A67B-11D07FFE3967 @default.
- Q65385192 P582 Q65385192-238FF85C-59A3-41F8-8ADF-839AFF49A47F @default.
- Q65385192 P6099 Q65385192-E7FC6CCA-01EE-416A-A36A-40446148D8C3 @default.
- Q65385192 P8363 Q65385192-2EAFB9CE-03E8-43FF-900D-AA5C0BFB65BC @default.
- Q65385192 P859 Q65385192-9A0DF1BE-5D1A-437D-A4A0-86C1336E3E22 @default.
- Q65385192 P1050 Q131742 @default.
- Q65385192 P1050 Q157661 @default.
- Q65385192 P1050 Q6853 @default.
- Q65385192 P1132 "+21" @default.
- Q65385192 P1476 "Stop Progression of Fibrosis by Administration of Intermittent Continuous Treatment With Peginterferon Alfa-2a. Open-label, Randomized Efficacy and Safety Clinical Trial of Intermittent Continuous Treatment With Peginterferon Alfa-2a (PEGASYS) in Patients With HBeAg Negative Hepatitis B Responding to Prior Treatment With Interferon Alfa (SOFIA -LTT)" @default.
- Q65385192 P17 Q219 @default.
- Q65385192 P2899 "+18" @default.
- Q65385192 P3098 "NCT00442572" @default.
- Q65385192 P31 Q30612 @default.
- Q65385192 P4844 Q20817235 @default.
- Q65385192 P580 "2006-07-03T00:00:00Z" @default.
- Q65385192 P582 "2012-04-23T00:00:00Z" @default.
- Q65385192 P6099 Q42824440 @default.
- Q65385192 P8363 Q78089383 @default.
- Q65385192 P859 Q212646 @default.